Sutro Biopharma EPS - Earnings per Share 2017-2020 | STRO

Sutro Biopharma eps - earnings per share from 2017 to 2020. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Sutro Biopharma Annual EPS
2019 $-2.43
2018 $-6.13
2017 $-43.95
2016 $4.17
Sutro Biopharma Quarterly EPS
2020-03-31 $-0.84
2019-12-31 $-0.65
2019-09-30 $-0.56
2019-06-30 $-0.60
2019-03-31 $-0.62
2018-12-31 $65.05
2018-09-30 $-21.26
2018-06-30 $-24.17
2018-03-31 $-25.75
2017-12-31 $0.00
2017-09-30 $-3.14
2016-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.203B $0.043B
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $148.880B 16.39
Bristol Myers Squibb (BMY) United States $130.987B 10.94
Gilead Sciences (GILD) United States $96.825B 12.55
CSL (CSLLY) Australia $88.639B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.183B 52.38
Regeneron Pharmaceuticals (REGN) United States $70.547B 27.19
Illumina (ILMN) United States $55.309B 56.83
Biogen (BIIB) United States $45.900B 7.86
Seattle Genetics (SGEN) United States $30.021B 0.00
Moderna (MRNA) United States $27.857B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.170B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.975B 10.30
Genmab (GMAB) Denmark $23.063B 19.00
BioMarin Pharmaceutical (BMRN) United States $22.863B 207.26
Incyte (INCY) United States $22.394B 0.00
Genmab (GNMSF) Denmark $21.777B 64.65
BioNTech SE (BNTX) Germany $18.979B 0.00
BeiGene (BGNE) Cayman Islands $18.504B 0.00
Alnylam Pharmaceuticals (ALNY) United States $18.138B 0.00
Exact Sciences (EXAS) United States $13.940B 0.00
Sarepta Therapeutics (SRPT) United States $13.005B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Galapagos (GLPG) Belgium $12.529B 36.85
ARGENX SE-ADR (ARGX) Netherlands $11.952B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.716B 26.37
QIAGEN (QGEN) Netherlands $10.561B 30.71
Bio-Techne Corp (TECH) United States $10.193B 67.34
Immunomedics (IMMU) United States $9.386B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.373B 0.00
Guardant Health (GH) United States $7.674B 0.00
Exelixis (EXEL) United States $7.298B 25.59
Ascendis Pharma (ASND) Denmark $6.614B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.600B 16.42
Repligen (RGEN) United States $6.530B 114.53
Novavax (NVAX) United States $6.374B 0.00
Vir Biotechnology (VIR) United States $5.846B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.633B 121.21
Adaptive Biotechnologies (ADPT) United States $5.488B 0.00
Acceleron Pharma (XLRN) United States $5.295B 0.00
Mirati Therapeutics (MRTX) United States $5.250B 0.00
Emergent Biosolutions (EBS) United States $5.068B 33.22
Ultragenyx Pharmaceutical (RARE) United States $5.028B 0.00
Zai Lab (ZLAB) China $4.978B 0.00
Reata Pharmaceuticals (RETA) United States $4.970B 0.00
MyoKardia (MYOK) United States $4.344B 0.00
Blueprint Medicines (BPMC) United States $4.334B 0.00
Global Blood Therapeutics (GBT) United States $4.286B 0.00
China Biologic Products (CBPO) China $4.223B 23.48
MorphoSys AG (MOR) Germany $4.202B 32.59
Inovio Pharmaceuticals (INO) United States $4.144B 0.00
Momenta Pharmaceuticals (MNTA) United States $4.036B 0.00
Amicus Therapeutics (FOLD) United States $3.875B 0.00
Halozyme Therapeutics (HALO) United States $3.853B 0.00
NeoGenomics (NEO) United States $3.719B 271.61
Bluebird Bio (BLUE) United States $3.497B 0.00
Arena Pharmaceuticals (ARNA) United States $3.381B 0.00
Alkermes (ALKS) Ireland $3.022B 59.50
Deciphera Pharmaceuticals (DCPH) United States $2.930B 0.00
Denali Therapeutics (DNLI) United States $2.725B 0.00
Insmed (INSM) United States $2.682B 0.00
Fate Therapeutics (FATE) United States $2.643B 0.00
Amarin (AMRN) Ireland $2.529B 0.00
PHARMA MAR SA (PHMMF) Spain $2.445B 0.00
Principia Biopharma (PRNB) United States $2.295B 0.00
Twist Bioscience (TWST) United States $2.187B 0.00
Viela Bio (VIE) United States $2.081B 0.00
UniQure (QURE) Netherlands $1.928B 0.00
Ligand Pharmaceuticals (LGND) United States $1.917B 74.64
Eidos Therapeutics (EIDX) United States $1.804B 0.00
I-Mab (IMAB) China $1.786B 0.00
Alector (ALEC) United States $1.778B 0.00
Editas Medicine (EDIT) United States $1.746B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.726B 0.00
Sorrento Therapeutics (SRNE) United States $1.665B 0.00
Cytokineticsorporated (CYTK) United States $1.658B 0.00
Intra-Cellular Therapies (ITCI) United States $1.570B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.561B 0.00
Sangamo Therapeutics (SGMO) United States $1.498B 0.00
Epizyme (EPZM) United States $1.495B 0.00
Adverum Biotechnologies (ADVM) United States $1.479B 0.00
REGENXBIO (RGNX) United States $1.439B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.431B 0.00
Mersana Therapeutics (MRSN) United States $1.423B 0.00
Zymeworks (ZYME) Canada $1.403B 0.00
Revance Therapeutics (RVNC) United States $1.383B 0.00
Zealand Pharma (ZEAL) Denmark $1.371B 0.00
Mesoblast (MESO) Australia $1.337B 0.00
NantKwest (NK) United States $1.332B 0.00
Arvinas (ARVN) United States $1.301B 0.00
Beam Therapeutics (BEAM) United States $1.292B 0.00
NGM Biopharmaceuticals (NGM) United States $1.253B 0.00
Akcea Therapeutics (AKCA) United States $1.238B 0.00
Coherus BioSciences (CHRS) United States $1.235B 8.62
Zealand Pharma (ZLDPF) Denmark $1.232B 0.00
Intellia Therapeutics (NTLA) United States $1.145B 0.00
Alcobra (ARCT) United States $1.137B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.106B 0.00
Arcus Biosciences (RCUS) United States $1.077B 0.00
VBI Vaccines (VBIV) United States $1.040B 0.00
Compugen (CGEN) Israel $0.997B 0.00
Athenex (ATNX) United States $0.982B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.911B 0.00
Retrophin (RTRX) United States $0.881B 0.00
Heska (HSKA) United States $0.870B 0.00
Myriad Genetics (MYGN) United States $0.860B 44.35
Dynavax Technologies (DVAX) United States $0.847B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.821B 0.00
Pharming Group (PHGUF) Netherlands $0.817B 21.75
Intrexon (PGEN) United States $0.773B 0.00
Morphic Holding (MORF) United States $0.758B 0.00
Castle Biosciences (CSTL) United States $0.740B 0.00
Vericel (VCEL) United States $0.734B 135.67
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.721B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.710B 0.00
Cellectis S.A (CLLS) France $0.703B 0.00
Kadmon Holdings (KDMN) United States $0.683B 0.00
Frequency Therapeutics (FREQ) United States $0.675B 0.00
Codexis (CDXS) United States $0.662B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.644B 5.52
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.607B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.605B 0.00
Agenus (AGEN) United States $0.604B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
MiMedx (MDXG) United States $0.594B 0.00
AnaptysBio (ANAB) United States $0.565B 0.00
Kala Pharmaceuticals (KALA) United States $0.560B 0.00
Athersys (ATHX) United States $0.554B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.522B 0.00
Cel-Sci (CVM) United States $0.522B 0.00
Syros Pharmaceuticals (SYRS) United States $0.520B 0.00
Anika Therapeutics (ANIK) United States $0.516B 16.59
Prothena (PRTA) Ireland $0.501B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.498B 0.00
UROGEN PHARMA (URGN) United States $0.495B 0.00
Clovis Oncology (CLVS) United States $0.489B 0.00
DBV Technologies S.A (DBVT) France $0.482B 0.00
AC Immune SA (ACIU) Switzerland $0.482B 0.00
MeiraGTx Holdings (MGTX) United States $0.458B 0.00
Scholar Rock Holding (SRRK) United States $0.437B 0.00
Protagonist Therapeutics (PTGX) United States $0.428B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.427B 0.00
BioDelivery Sciences (BDSI) United States $0.427B 22.42
Geron (GERN) United States $0.425B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.421B 0.00
Merus (MRUS) Netherlands $0.411B 0.00
Precision BioSciences (DTIL) United States $0.403B 0.00
Avid Bioservices (CDMO) United States $0.402B 0.00
Puma Biotechnology (PBYI) United States $0.394B 0.00
CytomX Therapeutics (CTMX) United States $0.393B 0.00
Kamada (KMDA) Israel $0.386B 16.04
Albireo Pharma (ALBO) United States $0.367B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.355B 0.00
ANI Pharmaceuticals (ANIP) United States $0.351B 6.83
WAVE Life Sciences (WVE) Singapore $0.345B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.337B 0.00
MannKind (MNKD) United States $0.335B 0.00
Affimed (AFMD) Germany $0.317B 0.00
OSMOTICA PHARM (OSMT) United States $0.317B 0.00
PDL BioPharma (PDLI) United States $0.315B 276.50
ChromaDex (CDXC) United States $0.307B 0.00
Seres Therapeutics (MCRB) United States $0.300B 0.00
Cellular Biomedicine (CBMG) United States $0.295B 0.00
Prometic Life Sciences (LMNL) Canada $0.295B 0.00
Starpharma Holdings (SPHRY) Australia $0.292B 0.00
Spero Therapeutics (SPRO) United States $0.277B 0.00
IBio (IBIO) United States $0.275B 0.00
Pfenex (PFNX) United States $0.270B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.264B 0.00
Menlo Therapeutics (MNLO) United States $0.263B 0.00
Northwest Biotherapeutics (NWBO) United States $0.257B 0.00
NextCure (NXTC) United States $0.250B 0.00
ADMA Biologics Inc (ADMA) United States $0.243B 0.00
Abeona Therapeutics (ABEO) United States $0.237B 0.00
Celldex Therapeutics (CLDX) United States $0.234B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.233B 0.00
Dyadic (DYAI) United States $0.230B 0.00
Verastem (VSTM) United States $0.228B 0.00
IVERIC Bio (ISEE) United States $0.223B 0.00
Fortress Biotech (FBIO) United States $0.223B 0.00
Five Prime Therapeutics (FPRX) United States $0.219B 0.00
Aduro Biotech (ADRO) United States $0.219B 0.00
HOOKIPA Pharma (HOOK) United States $0.215B 0.00
Selecta Biosciences (SELB) United States $0.213B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.210B 3.16
Pluristem Therapeutics (PSTI) Israel $0.209B 0.00
Aptinyx (APTX) United States $0.208B 0.00
Exicure (XCUR) United States $0.205B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.204B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
XOMA (XOMA) United States $0.195B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
Liquidia Technologies (LQDA) United States $0.190B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 0.00
Trevena (TRVN) United States $0.182B 0.00
ARAVIVE, INC (ARAV) United States $0.170B 0.00
Theratechnologies (THTX) Canada $0.169B 0.00
Kindred Biosciences (KIN) United States $0.161B 0.00
TELA Bio (TELA) United States $0.158B 0.00
Aytu Bioscience (AYTU) United States $0.157B 0.00
VolitionRX (VNRX) United States $0.155B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.153B 0.00
Bellus Health (BLU) Canada $0.153B 0.00
Celyad SA (CYAD) Belgium $0.153B 0.00
VTv Therapeutics (VTVT) United States $0.152B 0.00
CorMedix Inc (CRMD) United States $0.151B 0.00
Cerecor (CERC) United States $0.148B 0.00
Cidara Therapeutics (CDTX) United States $0.146B 0.00
Applied Genetic Technologies (AGTC) United States $0.145B 0.00
Gritstone Oncology (GRTS) United States $0.145B 0.00
AquaBounty Technologies (AQB) United States $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Biofrontera AG (BFRA) Germany $0.136B 0.00
Cyclerion Therapeutics (CYCN) United States $0.131B 0.00
Orgenesis (ORGS) United States $0.128B 0.00
Enzo Biochem (ENZ) United States $0.126B 0.00
Arbutus Biopharma (ABUS) United States $0.124B 0.00
Oncobiologics (OTLK) United States $0.123B 0.00
Lumos Pharma (LUMO) United States $0.117B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.117B 0.00
Palatin Technologies (PTN) United States $0.116B 2.99
Protalix BioTherapeutics (PLX) Israel $0.112B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.112B 0.00
AIT Therapeutics (XAIR) United States $0.105B 0.00
Eton Pharmaceuticals (ETON) United States $0.105B 0.00
Checkpoint Therapeutics (CKPT) United States $0.093B 0.00
Emmaus Life Sciences (EMMA) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.091B 0.00
Windtree Therapeutics (WINT) United States $0.090B 0.00
Cocrystal Pharma (COCP) United States $0.090B 0.00
Cardiff Oncology (CRDF) United States $0.090B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.089B 0.00
Unum Therapeutics (UMRX) United States $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.087B 0.00
DiaMedica Therapeutics (DMAC) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
Organovo Holdings (ONVO) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.075B 0.00
SESEN BIO, INC (SESN) United States $0.074B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.068B 0.00
Catalyst Biosciences (CBIO) United States $0.068B 0.00
Proteostasis Therapeutics (PTI) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Happiness Biotech Group (HAPP) China $0.066B 0.00
Stealth BioTherapeutics (MITO) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Synlogic (SYBX) United States $0.061B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
AnPac Bio-Medical Science (ANPC) China $0.058B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.057B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
CollPlant Holdings (CLGN) Israel $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
Signal Genetics (MGEN) United States $0.044B 0.00
Prima BioMed (IMMP) Australia $0.043B 0.00
Curis (CRIS) United States $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Edesa Biotech (EDSA) Canada $0.042B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Celsion (CLSN) United States $0.040B 0.00
ATyr Pharma (LIFE) United States $0.039B 0.00
Cleveland BioLabs (CBLI) United States $0.037B 0.00
Pulmatrix (PULM) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Advaxis (ADXS) United States $0.033B 0.00
OvaScience (MLND) United States $0.032B 0.00
Spherix (AIKI) United States $0.029B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Chanticleer Holdings (SONN) United States $0.028B 0.00
Cesca Therapeutics (THMO) United States $0.027B 0.00
IMMURON (IMRN) Australia $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Evogene (EVGN) Israel $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Prana Biotechnology (ATHE) Australia $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
FORTE BIOSCIENC (FBRX) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.021B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
BioCardia (BCDA) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
VIVUS (VVUS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00